VC-backed Lysogene taps Clancy for board chair
French gene therapy company Lysogene has named Annette Clancy as chair of the board of directors. Currently, Clancy is the board chair of Genable Technologies Ltd and ObsEva Ltd. Lysogene's backers include Sofinnova Partners.
20 April 2015•2 mins read
